Actinogen: ASX Investor Series Perth | Finance News Network

Actinogen: ASX Investor Series Perth

Company Presentations

by Carolyn Herbert

Actinogen Limited (ASX:ACW) CEO Dr Bill Ketelbey presents at the ASX Investor Series in Perth. 
 
The biotechnology group’s presentation is titled, “Developing Xanamem™ for Alzheimer’s Dementia”.
 
Dr Ketelbey describes Alzheimer’s as ‘one of the most significant health challenges of our time’.
 
The presentation looks at the company’s product Xanamem™, in development as a treatment for Alzheimer's disease and prodromal Alzheimer's/mild cognitive impairment.
 
Dr Ketelbey discusses Xanamem™’s pre-clinical data, development milestones, clinical advisory board and pipeline.
 
The presentation concludes with a summary of Actinogen’s financial profile, investment highlights and board and management. 

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.